We applied a multi-system approach involving studies in postmortem brain tissue from patients with Alzheimer’s disease compared to mouse models of tau- and amyloid precursor protein (APP)-associated neurotoxicity across disease stage, followed by mechanistic studies in a Drosophila model of tauopathy. The gene discussed is MAPT; the disease is tauopathy.